Agoracom Blog Home

Posts Tagged ‘tsx-v’

Universal PropTech Inc. $UPI.ca Announces Signing of Partnership with AtmosAir Solutions for Bi-Polar Ionization Products to Fight COVID-19 #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 8:20 AM on Wednesday, January 27th, 2021
  • Entered into a partnership with AtmosAir Solutions of Fairfield CT. to bring its products to market in Canada, including the company’s bi-polar ionization technology that mitigates COVID-19 and other viruses, bacteria and mold in the air and on surfaces.
  • UPI’s wholly-owned subsidiary, VCI Controls Inc. will promote, market, and sell AtmosAir products in Ontario and Quebec.

Toronto, Ontario–(January 27, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) announced today that is has entered into a partnership with AtmosAir Solutions of Fairfield CT. to bring its products to market in Canada, including the company’s bi-polar ionization technology that mitigates COVID-19 and other viruses, bacteria and mold in the air and on surfaces. UPI’s wholly-owned subsidiary, VCI Controls Inc. (“VCI”) will promote, market, and sell AtmosAir products in Ontario and Quebec.

“Our team is very excited to be taking this important step in our business plan with a reputable company such as AtmosAir,” said Chris Hazelton, President and CEO of UPI. “Their impressive client base is a testament to the quality of their solutions, and it is time such great technology was made readily available to our clients – existing and future. UPI is committed to seeking out the best-in-class technology solutions for our clients to fight the spread of COVID-19 whether by way of ownership, investment, licencing or master distribution arrangements. We are excited and committed to aggressively pursue schools, universities and colleges, long term care facilities and other governmental facilities to deliver results with our 40-year proven integrated HVAC and Building Controls company.”

Carlos Gendron, VP of Sales and Marketing at AtmosAir said, “Our current distribution has reached over 7,500 installations worldwide, mainly focused on United States and China. The quality of our products is evident from our roster of clients, which include marquee names involved in commercial real estate, health care, hospitals, assisted living, hotels, cruise lines, universities and sports facilities. We are pleased to work with the UPI team as we make our debut into Ontario and Quebec. VCI’s experience and long-standing track record is impressive and we look forward to showcasing our innovation in Canada with a credible partner such as UPI.”

AtmosAir products provide indoor air quality solutions that suppress airborne and surface microbials and pathogens, including coronavirus, other viruses, bacteria and mold, and reduce odors as well as unhealthy and irritating volatile organic compounds (VOCs). AtmosAir Solutions’ tested and proven air purification technology is a continuous disinfectant, removing airborne and surface contaminants from indoor spaces.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/754030-universal-proptech-inc-announces-signing-of-partnership-with-atmosair-solutions-for-bi-polar-ionization-products-to-fight-covid-19/messages/2300494#message

VIDEO – Universal #PropTech $UPI.ca Has Generated $35,000,000+ In Revenues Over Past 3 Years Delivering Healthy Building Solutions, Now Prepares To Deliver #COVID-19 Solutions To Tier-1 Clients Across Canada #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 4:16 PM on Tuesday, January 26th, 2021

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing PropTech industry, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada. 

More than just lip service, UPI clients include:

  • Federal Government facilities for over 40 years
  • Manulife
  • Brookfield
  • Billy Bishop Airport
  • University of Toronto
  • …. and many more

Now UPI is preparing to service those clients and take another big step forward with this announcement on January 25, 2021 – Universal PropTech Announces Signing of Canadian Distribution Agreement with Fresh-Aire UV to Help Combat SARS-CoV-2 in Schools, Colleges, Universities, Government Facilities and Seniors’ Homes.  What it means can best be summarized in the following quote by Chris Hazelton, President & CEO of UPI:

“Our clients expect us to have the right Covid-19-fighting solutions that meet the needs of their uniquely designed facilities.  Fresh-Aire UV solutions allow us to deliver a highly integrated HVAC package to fit those schools, colleges, universities, government facilities and seniors’ homes, immediately, and enable us to remain our customer’s trusted advisor in healthy buildings.”  

Watch our interview with CEO Hazelton to learn about the Company’s established PropTech success, COVID-19 solution for Canadian buildings and where the Company is going.

Novamind $NM.ca Announces Marketing Services Agreements $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:29 AM on Tuesday, January 26th, 2021
  • Entered into marketing services agreements with Octagon Media Corp.
  • AGORA Internet Relations Corp
  • And a consulting agreement with Venture North Capital Inc.

TORONTO, ON / January 26, 2021 / Novamind Inc., (CSE:NM) (“Novamind” or the “Company”) a mental health company specialized in psychedelic medicine, announces that is has entered into marketing services agreements with Octagon Media Corp. (“Octagon”) (the “Octagon Marketing Agreement”), AGORA Internet Relations Corp (“AGORA”) (the “AGORA Marketing Agreement”), and a consulting agreement with Venture North Capital Inc. (“VNC”) (the “VNC Agreement”).

In connection with the services provided by Octagon under the Octagon Marketing Agreement, the Company will pay Octagon a cash fee of US$123,000 upon signing, as well as grant Octagon a 12-month option to purchase 100,000 common shares in the capital of the company (the “Shares”) at a price of CAN$1.65 per Share, which will vest fully at signing, and 400,000 warrants to purchase Shares at a price of CAN$1.65 per Share for a period of twelve months from the date of issuance.

The Company also announces that it has entered into a 12-month online marketing services agreement with AGORA Internet Relations Corp., to carry out an online marketing campaign for the purposes of targeting new potential investors that would be specifically interested in the Company’s business model, as well as engaging current shareholders.

In connection with the services provided by AGORA under the AGORA Marketing Agreement, the Company will pay AGORA aggregate consideration of CAN$75,000 plus applicable taxes. The consideration is to be paid via the issuance of Shares. CAN$15,000 of Shares are payable upon commencement of the AGORA Marketing Agreement on January 15, 2021, in consideration of the setup and creation of tools to be used in connection with the services, and an additional CAN$15,000 of Shares are payable every three months thereafter until the end of the AGORA Marketing Agreement’s term.

The number and deemed price of the Shares to be issued will be determined after the date services are provided in each period and are to be calculated using the closing price of the Shares on the Canadian Securities Exchange on each date on which shares are to be issued.

The Company also announces that it has entered into a consulting agreement with Venture North Capital Inc., pursuant to which VNC will provide the Company with investor relations, marketing and communications services for a 6-month term.

In connection with the services provided by VNC under the VNC Agreement, the Company agreed to pay VNC a monthly cash payment of CAN$7,500 per month for six months. The Company has also agreed to issue VNC warrants to purchase 100,000 Shares at a price of CAN$1.65 per Share for a period of twelve months from the date of issuance.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

Contact Information

Novamind

Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512

Bill Mitoulas, Investor Relations
Email: [email protected]

Forward-Looking Statements

This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.

None of the securities discussed in this news released have been or will be registered under the United States Securities Act of 1933, as amended, or any state securities laws, and any securities issued are anticipated to be issued in reliance upon available exemptions from such registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

SOURCE: Novamind Inc.

AI/ML’s $AIML.ca $FIRZF Health Gauge announces successful Proof of Concept deployment and findings for study funded by The Bill and Melinda Gates Foundation $ADK.ca $PFM.ca $DM.ca

Posted by AGORACOM-JC at 8:09 AM on Tuesday, January 26th, 2021
  • Subsidiary, Health Gauge, successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology.
  • Health Gauge was invited in 2019 to participate, as the sole technology provider, in a Bill and Melinda Gates Foundation funded initiative with ICDDR , B (the International Centre for Diarrhoeal Disease Research of Bangladesh) on a research project to study ways to reduce pregnancy complications and mortality, by making healthcare more accessible using wearable solutions.

January 20, 2021 – AI/ML Innovations Inc. (CNSX :AIML.CN ) (OTC:FIRZF) , a company focused on acquiring and furthering Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that its subsidiary, Health Gauge, successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology. Health Gauge was invited in 2019 to participate, as the sole technology provider, in a Bill and Melinda Gates Foundation funded initiative with ICDDR , B (the International Centre for Diarrhoeal Disease Research of Bangladesh) on a research project to study ways to reduce pregnancy complications and mortality, by making healthcare more accessible using wearable solutions. Health Gauge was invited to participate in this study as a result of ICDDR,B’s learning of Health Gauge’s break-through solution in digital pulse and ECG analysis, using simple, affordable, and quality digital signal capture.  For this study, Health Gauge’s personal health monitoring solution, including its wearable device, smart phone app, and AI-driven cloud processing platform was used, in conjunction with the support of community-based health service providers.

Conclusion

Studies such as this validate the proof-of-concept of Health Gauge’s products, and show the vast and varied commercial opportunities available within Health Gauge’s bespoke business model. It speaks to the merits and importance of how Health Gauge’s latest generation solutions can help solve important community health problems, in affordable ways, while readily fitting into existing managed care programs – anywhere. Physicians, other healthcare professionals, and individuals can apply and adapt the Health Gauge solution to a number of different health conditions and settings for personal health monitoring and management – showing the larger value of Health Gauge’s device and applications.

Blood pressure related pregnancy maladies are of concern globally, and a leading cause of death amongst pregnant women. Health Gauge’s products have both the ability and opportunity to capitalize on this critical women’s health issue, while providing an invaluable service that has a direct impact on health outcomes.

Background

The study, which commenced in 2019, focused on serving pregnant women who were at risk of developing eclampsia, a hypertension-related significant health risk. Hypertensive disorders of pregnancy (HDP) are extremely dangerous to both the mother and child, and are in fact one of the three leading causes of maternal death worldwide. While hypertension complicates 10% of all pregnancies and is responsible for 14% for all maternal deaths globally, in the developing world it is of even greater concern where mortality rates can be as high as 20%.

Read More: https://agoracom.com/ir/AIMLInnovations/forums/discussion/topics/753924-ai-ml-s-health-gauge-announces-successful-proof-of-concept-deployment-and-findings-for-study-funded-by-the-bill-and-melinda-gates-foundation/messages/2300216#message

Novamind $NM.ca to Present at Inaugural KCSA Psychedelics Investor Conference $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:31 AM on Monday, January 25th, 2021
  • The two-day event will feature presentations by eminent psychedelics companies and industry leaders
  • Novamind CEO and Director Yaron Conforti will present on Wednesday, January 27th at 9:55 AM EST

TORONTO, ON / January 25, 2021 / Novamind Inc. (CSE:NM) (“Novamind” or the “Company”), a mental health company specialized in psychedelic medicine, today announced the Company’s participation at the Psychedelics Investor Conference, hosted by KCSA Strategic Communications on Tuesday, January 26th and Wednesday, January 27th from 9:00 AM – 12:30 PM EST.

The two-day event will feature presentations by eminent psychedelics companies and industry leaders. Novamind CEO and Director Yaron Conforti will present on Wednesday, January 27th at 9:55 AM EST.

“We look forward to connecting with industry leaders and investors to discuss Novamind’s operating model for clinical care and clinical research in psychedelic medicine,” said Conforti.

Read more: https://agoracom.com/ir/Novamind/forums/discussion/topics/753850-novamind-to-present-at-inaugural-kcsa-psychedelics-investor-conference/messages/2300029#message

Fabled $FCO.ca Drills 68.6 Meters of Continuous Silver Mineralization in Initial Drilling at Santa Maria $GGD.ca $EDR.ca $RDU.ca $KTN.ca $GMBXF $EDR.ca

Posted by AGORACOM at 7:54 AM on Monday, January 25th, 2021
Fabled Silver Gold Corp. (@Fabled_FCO) | Twitter

Fabled Silver Gold Corp. (TSXV: FCO) (FSE: 7NQ) (“Fabled” or the “Company”) is pleased to announce initial diamond drill results from the on-going 8,000-meter drill program on the Santa Maria Property in Parral, Mexico, with assays from two additional holes pending.

Peter J. Hawley, CEO and President remarks, “We are quite excited with the results from our first drill hole drilled to the east of the last underground workings and the exceptional wide intersection of 68.6 meters of continuous silver in shallow oxide mineralization. Within this broad zone, 20 meters reported 0.35 g/t Au, 106.29 g/t Ag and within this 20 meters, widths grading 146 g/t Ag, 238 g/t Ag and 151 g/t Ag were intersected (See Table 1 for widths and values). Drill holes SM20-02 and SM20-03 are drilled on the same section with the target being the sulphide intercept of this broad hydrothermal breccia zone, which is typically higher in grade due to metal values not being leached out by surface ground waters as commonly seen in oxide zones. The data being obtained from this fence of drill holes will not only target adding silver ounces to the overall resource but also allow us to interpret and model the behavior of this robust mineralized system for future drill hole success.”

Table 1: Drill Hole Intercepts

Hole NoFrom
(meters)
To (meters)Width
(meters)
g/t Aug/t Ag
SM20-00178.40147.0068.600.1843.98
Including112.00132.0020.000.35106.29
Including115.00117.002.000.27146.00
Including123.00124.601.601.09238.00
Including124.60126.501.900.34151.00

Drill hole SM20-01 was drilled at an angle of -45 degrees for a total hole depth of 164 meters. Drill hole SM20-02 was drilled at -65 degrees from the same station for a total hole depth and drill hole SM20-03 was stationed 75 meters behind the drill station for holes 01-02 and drilled at an angle of -75 degrees for a total depth of 375 meters.

Read More: https://agoracom.com/ir/FabledSilverGold/forums/discussion/topics/753841-fabled-drills-68-6-meters-of-continuous-silver-mineralization-in-initial-drilling-at-santa-maria/messages/2300012#message

Predictmedix Inc. $PMED.ca $PMEDF Provides Corporate Update

Posted by AGORACOM-JC at 7:44 AM on Monday, January 25th, 2021
Predictmedix Inc. (CSE: PMED | OTCQB: PMEDF) | LinkedIn
  • Initiatives and developments outlined below are in line with our larger goal of being the market leader in workplace health and safety by offering artificial intelligence powered technologies which address the major issues encountered in workplaces
  • Successfully deployed its technologies for beta testing purposes with major partners in North America and Asia, including India Oil (a fortune 500 corporation), MGM Hospital COVID-19 ward (one of the largest COVID-19 hospitals in Mumbai, India) and Flow Water.
  • Deployment at MGM Hospital is strategic to ensure our AI algorithms adapt to symptom associated changes brought on by new COVID-19 variants.
  • In other words, this allows our AI algorithm to adapt to the mutating virus.
  • Once learned, the technology is deployed immediately and is simultaneously functional across all present deployments.

TORONTO, Jan. 25, 2021 — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)(“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities. This update will outline current progress, advancements of the Company and shed light on other corporate developments as the past few months have been about laying the groundwork for our long-term success. The initiatives and developments outlined below are in line with our larger goal of being the market leader in workplace health and safety by offering artificial intelligence powered technologies which address the major issues encountered in workplaces. 

Public showcase of our technology in New York City

Predictmedix and Juiceworks’ Safe Entry Station will be showcased in a Live event on Jan 26, 2021 in New York City by Wellness4Humanity.

Wellness4Humanity’s New York City (NYC) flagship location opens at 225 West 34th Street near Pennsylvania Station in the heart of Herald Square in the two-story high-impact space formerly occupied by Lane Bryant. The flagship location will be showcasing a Safe Entry Station powered by Predictmedix’s proprietary infectious disease symptom screening technology.

– Here is a link to a demo of our technology: https://www.youtube.com/watch?v=phziV7OBkjY

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/753837-predictmedix-inc-provides-corporate-update/messages/2300006#message

VIDEO – Fabled Silver Gold $FCO.ca Mexican Silver Project Was So Good That CEO Peter Hawley Came Out Of Retirement $GGD.ca $EDR.ca $RDU.ca $KTN.ca

Posted by AGORACOM-JC at 4:00 PM on Friday, January 22nd, 2021
Fabled Silver Gold Corp. (@Fabled_FCO) | Twitter

Fabled Silver Gold controls 100% of the Santa Maria Gold and Silver property in Mexico. It is a high grade underground mine with a rich mining history and a Silver Equivalent 43-101 with 3.2million ounces Indicated and 1.1m inferred.

Now as far as silver projects go 3.2M ounces isn’t very big but when serial mine finder and industry stalwart Peter Hawley was presented with it in 2016, he came out of retirement saying “it was almost too good to be true” and “this is the one I’ve been looking for.

Santa Maria’s best historical intercept to date, reported 11meters of 1,672 g/t Silver & 3.74 g/t gold and ending in mineralization. Moreover, a 2018 PEA is very supportive at current market prices.

Santa Maria has never been systematically, or explored thoroughly with modern methods, until now.   FCO is currently conducting their first drill program to support the 43-101 and expects results to start flowing right into June.

It is definitely in a great “neighbourhood” in the mining friendly jurisdiction of Parral which has produced over 250M oz silver.  Moreover, multiple major operators in the vicinity, including three toll mills within a 20 km distance.

Watch this great first of many anticipated interviews with CEO Peter Hawley.

Binovi Technologies $VISN.ca $BNVIF Q3 2020 Revenue Up, Increasing Top-Line and Gross Margin Results $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 9:38 AM on Thursday, January 21st, 2021

Q3 2020 Financial Highlights:

  • Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019.
  • A combined $3.12 Million raised through private placement subscriptions with strategic investors.

January 21, 2021 – Toronto – Binovi Technologies Corp. (Binovi) (TSXV:VISN ) I ( OTC:BNVIF ) | ( GR:2EYA ) a leader in neuro-vision performance technology, reports results for the Company’s fiscal third quarter, ended November 30, 2020. The Company’s net sales results continue to be affected by the global health crisis. Increased demand for products across multiple categories led to an increase in top-line and gross margin results.

“Strategically positioned within telehealth, we believe the coming quarters will be pivotal in establishing our reputation and status as a competitor within this rapidly growing marketplace. While we are seeing strong growth across the business, it is important to recognize that we are making big investments in our people and infrastructure that are essential to support the significant growth that lies ahead. This includes big investments in our telehealth SaaS, our provider network, and personnel are critical as we scale the business,” stated Executive Chairman, Terry Booth.

Q3 2020 Financial Highlights:

  • Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019.
  • A combined $3.12 Million raised through private placement subscriptions with strategic investors.

Operational Highlights:

  • Since the launch of Binovi, more than 800 organizations have been registered and have used the platform for vision therapy and/or sports vision performance. These organizations have created nearly 31,000 users, together completing more than 400,000 active sessions centered around the Binovi Library list of activities, custom activities created by our member organizations.
  • Advanced the development of the company’s web-based telehealth SaaS, Binovi Connect. The beta launch of the platform is planned for Q1 2021.
  • Product marketing continues to grow brand awareness and promote sales, with an increase of 300% in website traffic, with improvements in direct media marketing and general top-of-mind awareness.

Read more: https://agoracom.com/ir/BinoviTechnologies/forums/discussion/topics/753563-binovi-technologies-q3-2020-revenue-up-increasing-top-line-and-gross-margin-results/messages/2299224#message

Victory Square $VST.ca $VSQTF Technologies Signs Binding Letter of Intent to Acquire IV Hydreight, An On-Demand & On-Site Mobile #Health, #Pharmaceutical & #Wellness Service Provider Across the United States $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 9:19 AM on Tuesday, January 19th, 2021
Victory Square Technologies | LinkedIn
  • Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical, health & wellness services through an on-demand and on-site platform.

  • In addition to providing telehealth services, Hydreight also provides a diverse suite of health & wellness protocols that include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments.

  • Hydreight is a USA certified e-script and telemedicine provider, allowing Hydreight to offer a wide array of health and medical services in all 50 states.

  • Hydreight provides full pharmaceutical offerings across the United States (Hydreight has full 503B Pharmaceutical supply capabilities ).
  • Hydreight has established key relationships and supply network chains with major vendors including: Medline, Mckesson, Allergan (Botox), Galderma and numerous pharmacies.

VANCOUVER, British Columbia, Jan. 19, 2021 — Victory Square Technologies Inc. (” Victory Square ” or the “ Company ”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that it has signed a binding letter of intent (the “ LOI ”) dated January 13, 2021 in respect of the acquisition (the “ Acquisition ”) of all of the shares of IV Hydreight Inc. (“ Hydreight ”), a mobile health and wellness service provider operating in the United States.

Founded in 2018, Hydreight provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office or wherever they may need discreet assistance. The business model of Hydreight leverages decentralized healthcare to bring quality telehealth, medical, health and wellness services to the masses in an efficient, scalable and cost effective way.

Read More: https://agoracom.com/ir/VictorySquareTechnologies/forums/discussion/topics/753355-victory-square-technologies-signs-binding-letter-of-intent-to-acquire-iv-hydreight-an-on-demand-on-site-mobile-health-pharmaceutical-wellness/messages/2298763#message